| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 349 |
| 1 | PREDNISONE | 115 |
| 2 | MYCOPHENOLATE MOFETIL | 89 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 89 |
| 4 | PREDNISOLONE | 89 |
| 5 | PREDNISOLONE ORAL | 89 |
| 6 | PREDNISOLONE ORAL SOLUTION | 89 |
| 7 | ADALIMUMAB | 88 |
| 8 | TACROLIMUS | 69 |
| 9 | RITUXIMAB | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 22 | 0.0454 |
| 1 | HUMAN IMMUNOGLOBULIN G | 349 | 0.0167 |
| 2 | EFGARTIGIMOD ALFA | 20 | 0.0050 |
| 3 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 17 | 0.0042 |
| 4 | AZATHIOPRINE SODIUM | 6 | 0.0024 |
| 5 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 13 | 0.0020 |
| 6 | BRENTUXIMAB VEDOTIN | 18 | 0.0017 |
| 7 | ERGOCALCIFEROL | 43 | 0.0014 |
| 8 | BUSULFAN | 23 | 0.0014 |
| 9 | RITUXIMAB-ABBS | 7 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 367 | 0.0174 |
| 1 | Endoglycosidase [EPC] | 22 | 0.0119 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 39 | 0.0089 |
| 3 | Benzodiazepine Antagonist [EPC] | 5 | 0.0056 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 15 | 0.0026 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 7 | CD30-directed Immunoconjugate [EPC] | 18 | 0.0017 |
| 8 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 9 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |